Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cal-X Stars operates as a 5-year business accelerator with a portfolio of breakthrough cardiovascular and social good innovations. The portfolio includes technologies such as MyoStim Pacers (heart failure pacemaker designed to recruit stem cells), Bioheart (Phase III leader in adult muscle stem cell therapy for heart failure), BioPace (biological pacemaker), and emerging technologies like the Stem Cell Bra. Over 600,000 patients have been treated with Leonhardt inventions to date.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cal-X Stars Business Accelerator.